CAMP Q2 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$80M-9.9% YoY

Gross Profit

$31M38.7% margin

Operating Income

-$10M-12.4% margin

Net Income

-$14M-18.0% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-8.0%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$480M

Total Liabilities

$355M

Stockholders' Equity

$125M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$89M	-9.9%
Gross Profit	$31M	$35M	-12.3%
Operating Income	-$10M	-$7M	-49.2%
Net Income	-$14M	-$9M	-65.9%

Revenue Segments

Product

$53M66%

Application Subscriptions And Other Services

$27M34%

Geographic Segments

UNITED STATES

$52M64%

E M E A

$16M20%

South America

$6M8%

All Other

$4M5%

Asia Pacific

$2M3%